Daniela Thorwarth1, Mike Notohamiprodjo2, Daniel Zips3, Arndt-Christan Müller3. 1. Section for Biomedical Physics, Department of Radiation Oncology, Eberhard Karls University Tübingen, Hoppe-Seyler-Strasse 3, Tübingen, Germany. Electronic address: daniela.thorwarth@med.uni-tuebingen.de. 2. Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Hoppe-Seyler-Strasse 3, Tübingen, Germany. 3. Department of Radiation Oncology, Eberhard Karls University Tübingen, Hoppe-Seyler-Strasse 3, Tübingen, Germany.
Abstract
BACKGROUND: To increase tumour control probability (TCP) in prostate cancer a method was developed integrating multi-parametric functional and biological information into a dose painting treatment plan aiming focal dose-escalation to tumour sub-volumes. A dose-escalation map was derived considering individual, multi-parametric estimated tumour aggressiveness. METHODS AND MATERIALS: Multi-parametric functional imaging (MRI, Choline-/PSMA-/FMISO-PET/CT) was acquired for a high risk prostate cancer patient with a high level of tumour load (cT3b cN0 cM0) indicated by subtotal involvement of prostate including the right seminal vesicle and by PSA-level >100. Probability of tumour presence was determined by a combination of multi-parametric functional image information resulting in a voxel-based map of tumour aggressiveness. This probability map was directly integrated into dose optimization in order to plan for inhomogeneous, biological imaging based dose painting. Histograms of the multi-parametric prescription function were generated in addition to a differential histogram of the planned inhomogeneous doses. Comparison of prescribed doses with planned doses on a voxel level was realized using an effective DVH, containing the ratio of prescribed vs. planned dose for each tumour voxel. RESULTS: Multi-parametric imaging data of PSMA, Choline and FMISO PET/CT as well as ADC maps derived from diffusion weighted MRI were combined to an individual probability map of tumour presence. Voxel-based prescription doses ranged from 75.3Gy up to 93.4Gy (median: 79.6Gy), whereas the planned dose painting doses varied only between 72.5 and 80.0Gy with a median dose of 75.7Gy. However, inhomogeneous voxel-based dose prescriptions can only be implemented into a treatment plan until a certain level. CONCLUSION: Multi-parametric probability based dose painting in prostate cancer is technically and clinically feasible. However, detailed calibration functions to define the necessary probability functions need to be assessed in future clinical trials.
BACKGROUND: To increase tumour control probability (TCP) in prostate cancer a method was developed integrating multi-parametric functional and biological information into a dose painting treatment plan aiming focal dose-escalation to tumour sub-volumes. A dose-escalation map was derived considering individual, multi-parametric estimated tumour aggressiveness. METHODS AND MATERIALS: Multi-parametric functional imaging (MRI, Choline-/PSMA-/FMISO-PET/CT) was acquired for a high risk prostate cancerpatient with a high level of tumour load (cT3b cN0 cM0) indicated by subtotal involvement of prostate including the right seminal vesicle and by PSA-level >100. Probability of tumour presence was determined by a combination of multi-parametric functional image information resulting in a voxel-based map of tumour aggressiveness. This probability map was directly integrated into dose optimization in order to plan for inhomogeneous, biological imaging based dose painting. Histograms of the multi-parametric prescription function were generated in addition to a differential histogram of the planned inhomogeneous doses. Comparison of prescribed doses with planned doses on a voxel level was realized using an effective DVH, containing the ratio of prescribed vs. planned dose for each tumour voxel. RESULTS: Multi-parametric imaging data of PSMA, Choline and FMISO PET/CT as well as ADC maps derived from diffusion weighted MRI were combined to an individual probability map of tumour presence. Voxel-based prescription doses ranged from 75.3Gy up to 93.4Gy (median: 79.6Gy), whereas the planned dose painting doses varied only between 72.5 and 80.0Gy with a median dose of 75.7Gy. However, inhomogeneous voxel-based dose prescriptions can only be implemented into a treatment plan until a certain level. CONCLUSION: Multi-parametric probability based dose painting in prostate cancer is technically and clinically feasible. However, detailed calibration functions to define the necessary probability functions need to be assessed in future clinical trials.
Authors: Constantinos Zamboglou; Vanessa Drendel; Cordula A Jilg; Hans C Rischke; Teresa I Beck; Wolfgang Schultze-Seemann; Tobias Krauss; Michael Mix; Florian Schiller; Ulrich Wetterauer; Martin Werner; Mathias Langer; Michael Bock; Philipp T Meyer; Anca L Grosu Journal: Theranostics Date: 2017-01-01 Impact factor: 11.556
Authors: E J Her; A Haworth; H M Reynolds; Y Sun; A Kennedy; V Panettieri; M Bangert; S Williams; M A Ebert Journal: Radiat Oncol Date: 2020-07-13 Impact factor: 3.481
Authors: Caterina Brighi; Paul J Keall; Lois C Holloway; Amy Walker; Brendan Whelan; Philip C de Witt Hamer; Niels Verburg; Farhannah Aly; Cathy Chen; Eng-Siew Koh; David E J Waddington Journal: Neurooncol Adv Date: 2022-08-19
Authors: Sebastian Zschaeck; Fabian Lohaus; Marcus Beck; Gregor Habl; Stephanie Kroeze; Constantinos Zamboglou; Stefan Alexander Koerber; Jürgen Debus; Tobias Hölscher; Peter Wust; Ute Ganswindt; Alexander D J Baur; Klaus Zöphel; Nikola Cihoric; Matthias Guckenberger; Stephanie E Combs; Anca Ligia Grosu; Pirus Ghadjar; Claus Belka Journal: Radiat Oncol Date: 2018-05-11 Impact factor: 3.481
Authors: Christopher Kurz; Giulia Buizza; Guillaume Landry; Florian Kamp; Moritz Rabe; Chiara Paganelli; Guido Baroni; Michael Reiner; Paul J Keall; Cornelis A T van den Berg; Marco Riboldi Journal: Radiat Oncol Date: 2020-05-05 Impact factor: 3.481